This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Insurance M&A Heats Up: The Doctors Company to Acquire ProAssurance
by Kaibalya Pravo Dey
PRA shareholders will receive $25 per share in cash from the $1.3 billion acquisition by The Doctors Company.
Should You Invest in the Invesco S&P 500 Equal Weight Financials ETF (RSPF)?
by Zacks Equity Research
Sector ETF report for RSPF
Why Is Willis Towers Watson (WTW) Up 4.3% Since Last Earnings Report?
by Zacks Equity Research
Willis Towers Watson (WTW) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
AJG Stock Gains 33.7% in a Year: A Signal for Investors to Hold Tight?
by Zacks Equity Research
Arthur J. Gallagher stock gains on the back of strategic acquisitions, solid retention and improving renewal premiums, as well as financial flexibility.
Are Finance Stocks Lagging Arthur J. Gallagher & Co. (AJG) This Year?
by Zacks Equity Research
Here is how Arthur J. Gallagher (AJG) and Citigroup (C) have performed compared to their sector so far this year.
Arthur J. Gallagher (AJG) Is Up 6.80% in One Week: What You Should Know
by Zacks Equity Research
Does Arthur J. Gallagher (AJG) have what it takes to be a top stock pick for momentum investors? Let's find out.
Willis Towers Q4 Earnings Surpass Estimates on Higher Revenues
by Zacks Equity Research
WTW's Q4 results reflect higher revenues and expanded operating margins at the Health, Wealth & Career and Risk & Broking segments as well as lower expenses.
Is Arthur J. Gallagher & Co. (AJG) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Here is how Arthur J. Gallagher (AJG) and Bank of America (BAC) have performed compared to their sector so far this year.
Should iShares Russell Mid-Cap ETF (IWR) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IWR
Arthur J. Gallagher Q4 Earnings Beat on Higher Commission and Fees
by Zacks Equity Research
AJG's fourth-quarter results reflect higher adjusted revenues, improved EBITDAC, as well as reduced expenses.
Watch These 5 Stocks That Recently Announced Dividend Hikes
by Santanu Roy
Investors may keep a tab on stocks like FBK, OFG, UTL, SCHW and AJG, which have lately hiked their dividend payments.
Arthur J. Gallagher (AJG) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Arthur J. Gallagher (AJG) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Arthur J. Gallagher (AJG) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Arthur J. Gallagher (AJG) delivered earnings and revenue surprises of 5.45% and 0.12%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Should iShares Morningstar Mid-Cap ETF (IMCB) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IMCB
Arthur J. Gallagher Set to Report Q4 Earnings: Is a Beat in Store?
by Zacks Equity Research
Better performances in both segments are likely to aid AJG's fourth-quarter results.
Will High Operating Costs Ail Marsh & McLennan in Q4 Earnings?
by Zacks Equity Research
MMC's Q4 results are likely to be aided by strength in the Risk and Insurance Services and Consulting segments, partly offset by elevated compensation and benefits expenses.
Should iShares Russell Mid-Cap Value ETF (IWS) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IWS
Should iShares Morningstar Mid-Cap Growth ETF (IMCG) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IMCG
Arthur J. Gallagher (AJG) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Arthur J. Gallagher (AJG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
L.A. Wildfires: 3 Insurance Stocks Standing Strong Amid Recovery
by Kaibalya Pravo Dey
Insurers can become a guiding force for recovery, which is important because a rising tide will often lift all boats in an industry.
Should Vanguard Mid-Cap Value ETF (VOE) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VOE
Compelling Reasons to Hold on to Arthur J. Gallagher Stock for Now
by Zacks Equity Research
AJG gains on the back of strategic acquisitions, solid retention and improving renewal premiums, as well as financial flexibility
Should You Buy, Sell or Hold Marsh & McLennan Stock at a 7.47X P/B?
by Zacks Equity Research
MMC is currently aided by strong segmental contribution, margin expansion and inorganic growth initiatives.
Zacks Industry Outlook Brown and Brown, Marsh & McLennan, Arthur J. Gallagher & Co and Willis Towers Watson
by Zacks Equity Research
Brown and Brown, Marsh & McLennan, Arthur J. Gallagher & Co and Willis Towers Watson have been highlighted in this Industry Outlook article.
4 Stocks to Watch From the Prospering Insurance Brokerage Industry
by Sushmita Sarker
Higher demand for insurance products, strategic acquisitions and the adoption of technology should drive the performance of Zacks Insurance Brokerage industry players like BRO, MMC, AJG and WTW.